Robert J. Bitterman - Jun 7, 2024 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
President & CEO, Director
Signature
/s/ Caitlin Kontulis, attorney-in-fact
Stock symbol
PHIO
Transactions as of
Jun 7, 2024
Transactions value $
$740
Form type
4
Date filed
6/11/2024, 05:00 PM
Previous filing
Jun 10, 2024
Next filing
Sep 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $740 +1K +5% $0.74 21K Jun 7, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.